Covaxin may be made available for children above 2 years in September says Dr.Randeep Guleria,AIIMS Chief
Dr Randeep Guleria AIIMS Delhi Director today said that Bharat Biotech’s Covaxin vaccine’s data for children aged 2-17 years after completion of the Phase 2/3 trials should be available by … Read More
